Kabi Awaits Melrose Park Fate As mAbxience Deal Closes

€455m Deal For 55% Stake In Biosimilars Business Closed 1 August

Fresenius Kabi is pressing on with its ‘Vision 2026’ strategic growth initiatives, with the company wrapping up its acquisition of Insud Pharma’s bio unit mAbxience. However, it remains “to some degree output constrained,” which looks set to continue to impact operations, amid staff shortages.

NicoElNino/Alamy Stock Photo
Kabi now holds a 55% stake in mabxience • Source: Shutterstock (NicoElNino / Alamy Stock Photo/Alamy Stock Photo)

Fresenius Kabi’s large-scale sterile injectables plant in Melrose Park near Chicago, which was in 2020 the recipient of multiple Form 483 deficiencies, has received its long-awaited US Food and Drug Administration inspection, the German firm has confirmed.

“We expect feedback over the course of the third quarter,” the Fresenius group CEO Stephan Sturm told investors during the...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Biosimilars

More from Products

  • For Generics, A Victory Lap – And A Warning – On Drug Shortages

    Avoiding disaster at the beginning of the pandemic and offering a pro-active supply chain blueprint should position the generics industry well for an onshoring debate in Congress, but a look back at March 2020 is a reminder that even small policy shifts can have a big impact.

  • GB-Free-Company-The Secret to Walking More: It’s Not Counting Steps

    We’ve all been told that walking 10,000 steps a day is the magic number for better health. But what if the real secret to walking more isn’t about counting steps at all? In this article, we explore how focusing on motivation, environment, and mindset can help you build a walking habit that lasts.

  • Biocon And Teva Sign Up To Biosimilars Forum

    Teva and Biocon Biologics have become the latest firms to sign up to the Biosimilars Forum industry association in the US.